---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-047617"
form_type: "8-K"
ticker: "NSPR"
cik: "0001433607"
company_name: "InspireMD, Inc."
filed_at: "2024-11-25T23:59:59+00:00"
generated_at: "2026-05-29T18:47:59.152605+00:00"
event_type: "leadership"
sentiment: "positive"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# InspireMD appoints medtech executive Scott R. Ward to Board of Directors

## Summary
- Scott R. Ward, former CEO of Cardiovascular Systems and Abbott leader, joins as Class II director.
- Ward received options for 16,647 shares and 43,548 restricted stock, vesting on one-year anniversary.
- Management highlights Ward's cardiovascular expertise ahead of potential U.S. approval of CGuard Prime.
- Ward has over 40 years healthcare experience, including 30 years at Medtronic in senior leadership roles.

## SEC filing metadata
- accession: 0001493152-24-047617
- form_type: 8-K
- ticker: NSPR
- cik: 0001433607
- company_name: InspireMD, Inc.
- filed_at: 2024-11-25T23:59:59+00:00
- event_type: leadership
- sentiment: positive
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1433607/000149315224047617/0001493152-24-047617-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1433607/000149315224047617/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-047617
- JSON: https://secwatch.observer/filing/0001493152-24-047617.json
- Plain text: https://secwatch.observer/filing/0001493152-24-047617.txt

## Key facts
- Executive change
  Scott R. Ward was appointed as Class II member of the Board at InspireMD, Inc..
  - Action: appointed
  - Role: Class II member of the Board
  source text: On November 25, 2024, the board of directors of InspireMD, Inc. (the “Board” and the “Company”, respectively) appointed Mr. Scott R. Ward as a Class II member of the Board, effective as of that date, with a term expiring at the Company’s 2025 annual meeting of stockholders.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1433607/000149315224047617/0001493152-24-047617-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.